Review
doi: 10.1017/s0317167100020047.
Progress in understanding Huntington's chorea
- PMID: 124199
- DOI: 10.1017/s0317167100020047
Item in Clipboard
Review
Progress in understanding Huntington's chorea
Can J Neurol Sci.
1975 May.
Abstract
The present paper analyses the new data accumulated since 1972 concerning the etiology and pathogenesis of Huntington's chorea. Particular attention is paid to the respective roles of the dopaminergic and GABA-ergic systems.
Similar articles
-
Huntington's chorea. Changes in neurotransmitter receptors in the brain.N Engl J Med. 1976 Jun 10;294(24):1305-9. doi: 10.1056/NEJM197606102942402. N Engl J Med. 1976. PMID: 4733
-
[Neuropharmacologic approach in Huntington's chorea].Rev Neurol (Paris). 1975 Dec;131(12):847-65. Rev Neurol (Paris). 1975. PMID: 134438 Review. French. No abstract available.
-
Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea.J Neurochem. 1976 Jan;26(1):65-76. J Neurochem. 1976. PMID: 3629 No abstract available.
-
[Neurotransmitters in Huntington chorea (review)].Zh Nevropatol Psikhiatr Im S S Korsakova. 1985;85(3):444-50. Zh Nevropatol Psikhiatr Im S S Korsakova. 1985. PMID: 2581405 Review. Russian. No abstract available.
-
Editorial: Dopamine and G.A.B.A. in Huntington's chorea.Lancet. 1974 Nov 9;2(7889):1122-3. Lancet. 1974. PMID: 4139415 No abstract available.
Cited by
-
The muscarinic M4 acetylcholine receptor exacerbates symptoms of movement disorders.Biochem Soc Trans. 2023 Apr 26;51(2):691-702. doi: 10.1042/BST20220525. Biochem Soc Trans. 2023. PMID: 37013974 Free PMC article. Review.
-
MR-based spatial normalization improves [18F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington's disease.PLoS One. 2018 Oct 26;13(10):e0206613. doi: 10.1371/journal.pone.0206613. eCollection 2018. PLoS One. 2018. PMID: 30365550 Free PMC article.
-
[Monoamine oxidase activity in brain regions and organs of patients with Parkinson's disease and Huntington's disease and serum MAO activity of patients with Huntington's disease as compared with neurologically healthy individuals (author's transl)].Arch Psychiatr Nervenkr (1970). 1981;230(1):5-15. doi: 10.1007/BF00343762. Arch Psychiatr Nervenkr (1970). 1981. PMID: 6455104 German.